loader image
PharmEnable wins Rising Star at UKBAA Angel Investment Award

PharmEnable wins Rising Star at UKBAA Angel Investment Award

We are delighted to announce that PharmEnable has been awarded Rising Star in the DeepTech Investment of the Year category at the UKBAA Angel Investment Awards 2021. The annual UKBAA Angel Investment awards, sponsored by Playfair Capital, recognise acknowledge the...
PharmEnable welcome new Director of Drug Discovery

PharmEnable welcome new Director of Drug Discovery

PharmEnable are delighted to welcome Dr James Dale as Director of Drug Discovery. Dr Dale has over 18 years of experience in research and drug discovery, focusing on identifying and delivering novel therapeutics. He earned a PhD in synthetic organic chemistry and has...
Our CEO joins live debate panel this week

Our CEO joins live debate panel this week

Our CEO, Dr Hannah Sore, will be speaking at this week’s #coffeebuddies debate series, in association with One Nucleus. The virtual #coffeebuddies debates are a fringe event to ON Helix and keep the life sciences community connected, engaged, informed and entertained....
PharmEnable appoints new Board Chair

PharmEnable appoints new Board Chair

PharmEnable are delighted to announce the appointment of Dr Jane Dancer as Chair of our Board of Directors. She brings with her a wealth of experience in business development and driving company growth. Her previous roles include Chief Business Officer at F-star...
Director of Molecular Informatics and AI

Director of Molecular Informatics and AI

PharmEnable are delighted to announce and welcome Dr David Vidal as our new Director of Molecular Informatics and AI. Dr Vidal brings with him an impressive background in computational chemistry, with expertise in machine learning/AI. He has a PhD in Organic Chemistry...